☰

Mark Stein - Publications

Affiliations: 
2011- Professor, Psychiatry  
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Stein MA. Editorial: Treating Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children With Stimulants: Modest Effects in Young Children With Big Problems. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 35724816 DOI: 10.1016/j.jaac.2022.06.005  0.309
2022 Weiss MD, Stein MA. Measurement Informed Care in Attention-Deficit/Hyperactivity Disorder (ADHD). Child and Adolescent Psychiatric Clinics of North America. 31: 363-372. PMID 35697390 DOI: 10.1016/j.chc.2022.03.010  0.308
2022 Arnett AB, Rutter TM, Stein MA. Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder. Frontiers in Behavioral Neuroscience. 16: 887622. PMID 35600991 DOI: 10.3389/fnbeh.2022.887622  0.303
2021 Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, Newcorn JH, Gignac M, Al Saud NM, Manor I, Rohde LA, Yang L, Cortese S, Almagor D, Stein MA, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder. Neuroscience and Biobehavioral Reviews. PMID 33549739 DOI: 10.1016/j.neubiorev.2021.01.022  0.305
2019 Schoenfelder EN, Chronis-Tuscano A, Strickland J, Almirall D, Stein MA. Piloting a Sequential, Multiple Assignment, Randomized Trial for Mothers with Attention-Deficit/Hyperactivity Disorder and Their At-Risk Young Children. Journal of Child and Adolescent Psychopharmacology. PMID 30950637 DOI: 10.1089/Cap.2018.0136  0.316
2018 Arnett A, Stein M. Refining treatment choices for ADHD. The Lancet. Psychiatry. PMID 30097391 DOI: 10.1016/S2215-0366(18)30295-5  0.388
2017 Kim SJ, Shonka S, French WP, Strickland J, Miller L, Stein MA. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study. Journal of Autism and Developmental Disorders. PMID 28474229 DOI: 10.1007/s10803-017-3125-1  0.333
2017 Newcorn J, Krone B, Hildebrandt T, Stein M. 856. Methylphenidate vs. Atomoxetine in Youth with ADHD: Comparative Effectiveness and Preference following Treatment with both Medications Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.581  0.367
2017 Stein M, Bishop J, Cook E, Zhou C, Newcorn J. 855. Response to Methylphenidate and Atomoxetine in Children with ADHD: Pharmacogenetic Predictors Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.580  0.376
2016 Sasser T, Schoenfelder EN, Stein MA. Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD. Cns Drugs. PMID 27943133 DOI: 10.1007/s40263-016-0400-1  0.301
2016 Su Y, Yang L, Stein MA, Cao Q, Wang Y. Osmotic Release Oral System Methylphenidate versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-up. Journal of Child and Adolescent Psychopharmacology. PMID 26779845 DOI: 10.1089/cap.2015.0031  0.31
2015 Stein MA, Sikirica V, Weiss MD, Robertson B, Lyne A, Newcorn JH. Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial. Cns Drugs. PMID 26547425 DOI: 10.1007/s40263-015-0291-6  0.33
2015 Hammer R, Cooke GE, Stein MA, Booth JR. Functional neuroimaging of visuospatial working memory tasks enables accurate detection of attention deficit and hyperactivity disorder. Neuroimage. Clinical. 9: 244-52. PMID 26509111 DOI: 10.1016/J.Nicl.2015.08.015  0.464
2015 Hammer R, Tennekoon M, Cooke GE, Gayda J, Stein MA, Booth JR. Feedback associated with expectation for larger-reward improves visuospatial working memory performances in children with ADHD. Developmental Cognitive Neuroscience. 14: 38-49. PMID 26142072 DOI: 10.1016/J.Dcn.2015.06.002  0.469
2015 Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 56: 40-8. PMID 24942409 DOI: 10.1111/Jcpp.12272  0.318
2014 Santisteban J, Stein M, Gruber R. 53: Effects of Dosage on Sleep Duration During Stimulant Treatment of ADHD in Youth Paediatrics & Child Health. 19: e54-e55. DOI: 10.1093/Pch/19.6.E35-52  0.319
2013 Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 921-30. PMID 23972694 DOI: 10.1016/j.jaac.2013.06.006  0.316
2013 Stein M. The war on ADHD Nature Medicine. 19: 1566-1566. DOI: 10.1038/Nm.3419  0.417
2011 Shook D, Brady C, Lee PS, Kenealy L, Murphy ER, Gaillard WD, VanMeter JW, Cook EH, Stein M, Vaidya CJ. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 28-35. PMID 20957668 DOI: 10.1002/Ajmg.B.31132  0.395
2011 Stein M, Youcha S, White C, Enright G, Rubin J. Efficacy of guanfacine extended release, administered in the morning or evening, in the treatment of children with attention-deficit/hyperactivity disorder F1000research. 2. DOI: 10.7490/F1000Research.1328.1  0.391
2010 Lee SH, Shin DW, Stein MA. Increased cortisol after stress is associated with variability in response time in ADHD children. Yonsei Medical Journal. 51: 206-11. PMID 20191011 DOI: 10.3349/ymj.2010.51.2.206  0.312
2008 Stein MA, McGough JJ. The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy. Child and Adolescent Psychiatric Clinics of North America. 17: 475-90, xi-xii. PMID 18295157 DOI: 10.1016/j.chc.2007.11.009  0.315
2007 Newcorn JH, Weiss M, Stein MA. The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. Cns Spectrums. 12: 1-14; quiz 15-6. PMID 17667893  0.333
2006 McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 16: 351-6. PMID 16768642 DOI: 10.1089/Cap.2006.16.351  0.36
2005 Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: Final results from a long-term open-label study Journal of the American Academy of Child and Adolescent Psychiatry. 44: 1015-1023. PMID 16175106 DOI: 10.1097/01.chi.0000173291.28688.e7  0.328
2003 Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 112: e404. PMID 14595084 DOI: 10.1542/Peds.112.5.E404  0.339
2003 Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 424-33. PMID 12649629 DOI: 10.1097/01.Chi.0000046814.95464.7D  0.329
2002 Hartung CM, Willcutt EG, Lahey BB, Pelham WE, Loney J, Stein MA, Keenan K. Sex differences in young children who meet criteria for attention deficit hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 31: 453-64. PMID 12402565 DOI: 10.1207/S15374424Jccp3104_5  0.324
1998 Lahey BB, Pelham WE, Stein MA, Loney J, Trapani C, Nugent K, Kipp H, Schmidt E, Lee S, Cale M, Gold E, Hartung CM, Willcutt E, Baumann B. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. Journal of the American Academy of Child and Adolescent Psychiatry. 37: 695-702. PMID 9666624 DOI: 10.1097/00004583-199807000-00008  0.311
1997 Weiss RE, Stein MA, Refetoff S. Behavioral effects of liothyronine (L-T3) in children with attention deficit hyperactivity disorder in the presence and absence of resistance to thyroid hormone Thyroid. 7: 389-393. PMID 9226208 DOI: 10.1089/Thy.1997.7.389  0.306
1995 Stein MA, Weiss RE, Refetoff S. Neurocognitive characteristics of individuals with resistance to thyroid hormone: Comparisons with individuals with attention-deficit hyperactivity disorder Journal of Developmental and Behavioral Pediatrics. 16: 406-411. PMID 8746549  0.326
1995 Stein MA, Szumowski E, Blondis TA, Roizen NJ. Adaptive skills dysfunction in ADD and ADHD children Journal of Child Psychology and Psychiatry. 36: 663-670. PMID 7650089  0.318
1995 STEIN MA, WEISS RE, REFETOFF S. Neurocognitive Characteristics of Individuals with Resistance to Thyroid Hormone Journal of Developmental & Behavioral Pediatrics. 16: 406???411. DOI: 10.1097/00004703-199512000-00003  0.316
1994 Roizen NJ, Blondis TA, Stein M, Irwin M. Adaptive Functioning in Children With Attention-Deficit Hyperactivity Disorder Archives of Pediatrics & Adolescent Medicine. 148: 1137-1142. PMID 7921113 DOI: 10.1001/Archpedi.1994.02170110023004  0.383
Show low-probability matches.